ambrisentan

Manufacturer:
Gilead
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
Enrollment Forms:
Synergen Prescription Form

Approved Indication:

To improve exercise ability and delay clinical worsening in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening WHO group 1 pulmonary arterial hypertension

Conditions:

  • Pulmonary Arterial Hypertension